Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Arrowhead Publishers | The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry. An increase in the number of aged people, increased life expectancy, unmet clinical needs together with advances in treatments of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease will continue to contribute to the expansion of the global market.

This report provides an insight into the neurodegenerative market, neurotherapeutic drugs currently available, and upcoming products. This report specifically focuses on key CNS diseases, such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s disease, and neuropathies. Profiles of leading companies that are active in R&D in these areas are included.

The report presents, in detail, an overview of the current global market for neurodegenerative drugs for selected neurological diseases, including currently marketed and forthcoming neurotherapeutic products. Market analysis and assessment for key neurodegenerative therapies is done across major pharmaceutical markets in United States (US)/North America, Europe and Japan.

Key features of this report:

Statistical information for selected neurological diseases

Overview of the disease, key therapies, market size and growth, market composition by region, as well as market outlook and forecast

Global sales figures for key neurodegenerative therapies

Financial forecasts by disease and key product

Description of neurotherapeutic products currently on the market, including a description of products in the pipeline

Company profiles of major pharmaceutical providers active in R&D in these areas

The report also deals with factors affecting growth, new drug therapies, and clinical research in the completion stages.

The diseases/conditions addressed in the report include:

Alzheimer’s disease

Parkinson’s disease

Multiple sclerosis

Amyotrophic lateral sclerosis

Huntington’s disease

Neuropathies

Publication Date: January 31, 2007 Format PDF
Table of Contents

Price

Single User PDF $2250.00

Site Licence PDF $4499.00

Corporate Wide Licence PDF $5499.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions